Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 7, Number 2—April 2001
THEME ISSUE
4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections

State of the Art

Building Communication Networks: International Network for the Study and Prevention of Emerging Antimicrobial Resistance (INSPEAR)

Hervé M. Richet*Comments to Author , Jasmine Mohammed*, L. Clifford McDonald†, William R. Jarvis*, and INSPEAR
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †National Health Research Institute, Taipei, Taiwan

Main Article

Table 1

Early warning system: global sentinel events

Microorganism Resistance
Streptococcus spp. Penicillinase, gentamicin, glycopeptides, fluoroquinolones
S. pneumoniae Vancomycin, third-generation cephalosporins, new fluoroquinolones (gemifloxacine, grepafloxacin, levofloxacin, trovafloxacin)
Staphylococcus spp. Glycopeptides (high level)
Enterobacteriaceae Carbapenemase
Neisseria meningitidis Penicillinase, chloramphenicol, cephalosporins, fluoroquinolones
Acinetobacter baumannii Carbapenemase
Salmonella typhi Third-generation cephalosporins, fluoroquinolones
Haemophilus influenzae Cephalosporins
Brucella spp. Tetracycline, rifampin, streptomycin
Clostridium difficile Glycopeptides
Clostridium perfringens Penicillinase

Main Article

1D. Pittet, D.F. Brown, A.G. Dean, S. Gordon, I.M. Gould, M. Gubina, P. Heczko, M. Pana, J. Schindler, M.J. Struelens, F. Tenover, J. Vuopio-Varkila, A. Widmer, W. Witte.

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO